← Back
$VRCA All transactions

Verrica Pharmaceuticals Inc.

▲ BUY
8 / 10

Conviction

$ Value

Shares

884

Price

Filed

Nov 25

Why this score? (8/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Cluster: 5 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Kirby John J.

Title

Interim CFO

CIK

0001556327

Roles

Officer

Transaction Details

Transaction Date

2025-11-25

Code

P

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

884

Footnotes

Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. | Immediately exercisable. | The reported securities are included within 3,536 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

Filing Info

Accession No.

0001556327-25-000004

Form Type

4

Issuer CIK

0001660334

Kirby John J.'s History

Date Ticker Type Value
2025-12-23 VRCA A $0
2025-11-25 VRCA $15K
2025-11-25 VRCA

Other Insiders at VRCA (90d)

No other insider activity at this issuer in the last 90 days.